<i>Campylobacter fetus</i> Bacteremia with Purulent Pleurisy in a Young Adult with Primary Hypogammaglobulinemia

  • Yamagami Keiko
    Department of Internal Medicine, Osaka City General Hospital, Japan
  • Miyashita Tomoko
    Department of Internal Medicine, Osaka City General Hospital, Japan
  • Nakamura Tomoyuki
    Department of Internal Medicine, Osaka City General Hospital, Japan
  • Shirano Michinori
    Department of Infectious Disease, Osaka City General Hospital, Japan
  • Nakamura Tadahiro
    Department of Infectious Disease, Osaka City General Hospital, Japan
  • Kameda Kazuaki
    Department of Infectious Disease, Osaka City General Hospital, Japan
  • Nishijima Masayoshi
    Department of Pulmonary Disease, Osaka City General Hospital, Japan
  • Imanishi Masahiro
    Department of Internal Medicine, Osaka City General Hospital, Japan
  • Yang Xi
    Department of Pediatrics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan
  • Kanegane Hirokazu
    Department of Pediatrics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Japan

この論文をさがす

抄録

A 24-year-old man presented with fever and pleural effusion predominantly containing lymphocytes. Cultures of the pleural effusion and blood revealed Campylobacter fetus, and laboratory studies showed a low serum level of immunoglobulin. The patient was diagnosed with C. fetus pleuritis, bacteremia and primary hypogammaglobulinemia, and subsequent treatment with meropenem and immunoglobulin improved his condition. Although the underlying cause of the primary hypogammaglobulinemia remains unclear, the patient's status improved under immunoglobulin replacement therapy. C. fetus pleuritis is a rare infectious disease usually observed in immunocompromised hosts. We herein describe the first report of C. fetus pleuritis in a young adult with primary hypogammaglobulinemia.<br>

収録刊行物

  • Internal Medicine

    Internal Medicine 53 (11), 1221-1225, 2014

    一般社団法人 日本内科学会

被引用文献 (1)*注記

もっと見る

参考文献 (12)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ